Pages that link to "Q33845614"

The following pages link to Multiple-dose, linear, dose-proportional pharmacokinetics of retigabine in healthy volunteers (Q33845614):

Displaying 40 items.

• New and emerging treatments for epilepsy: review of clinical studies of lacosamide, eslicarbazepine acetate, ezogabine, rufinamide, perampanel, and electrical stimulation therapy (Q27007942) (← links)
• Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions (Q28245021) (← links)
• Pharmacokinetics and elucidation of the rates and routes of N-glucuronidation of PF-592379, an oral dopamine 3 agonist in rat, dog, and human (Q34137634) (← links)
• Retigabine/Ezogabine, a KCNQ/K(V)7 channel opener: pharmacological and clinical data (Q34333196) (← links)
• Lack of effect of ezogabine/retigabine on the pharmacokinetics of digoxin in healthy individuals: results from a drug-drug interaction study (Q34386899) (← links)
• Retigabine: chemical synthesis to clinical application. (Q34415600) (← links)
• Retigabine: in partial seizures (Q34541901) (← links)
• Pharmacological management of epilepsy: recent advances and future prospects (Q34823174) (← links)
• Ezogabine: a new angle on potassium gates (Q35052160) (← links)
• Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures (Q35117817) (← links)
• Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine. (Q35683922) (← links)
• Clinical utility of adjunctive retigabine in partial onset seizures in adults. (Q35717049) (← links)
• Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsy (Q36144410) (← links)
• Ezogabine (KCNQ2/3 channel opener) prevents delayed activation of meningeal nociceptors if given before but not after the occurrence of cortical spreading depression (Q36980156) (← links)
• Efficacy of retigabine in adjunctive treatment of partial onset seizures in adults (Q37302567) (← links)
• Kv7 voltage-activated potassium channel inhibitors reduce fluid resuscitation requirements after hemorrhagic shock in rats (Q37589301) (← links)
• Emerging drugs for partial onset seizures. (Q37754477) (← links)
• Retigabine: the newer potential antiepileptic drug. (Q37761269) (← links)
• Pharmacotherapy of epilepsy: newly approved and developmental agents (Q37831297) (← links)
• Retigabine (ezogabine): in partial-onset seizures in adults with epilepsy (Q37936428) (← links)
• Novel medications for epilepsy (Q37950518) (← links)
• Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate (Q37992162) (← links)
• Retigabine for partial onset seizures. (Q38006978) (← links)
• Ezogabine: an evaluation of its efficacy and safety as adjunctive therapy for partial-onset seizures in adults (Q38044694) (← links)
• Ezogabine: a novel antiepileptic for adjunctive treatment of partial-onset seizures (Q38079563) (← links)
• The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs (Q38621010) (← links)
• Modulation of the heart's electrical properties by the anticonvulsant drug retigabine. (Q38699306) (← links)
• New antiepileptic drugs: focus on ezogabine, clobazam, and perampanel (Q38851234) (← links)
• Investigation of the impact of urine handling procedures on interpretation of urinalysis findings and product safety in subjects treated with ezogabine (Q40615041) (← links)
• Cardiovascular responses to retigabine in conscious rats--under normotensive and hypertensive conditions (Q41771260) (← links)
• The anticonvulsant retigabine is a subtype selective modulator of GABAA receptors. (Q42212418) (← links)
• Retigabine (ezogabine) as add-on therapy for partial-onset seizures: an update for clinicians (Q42385228) (← links)
• Lack of pharmacokinetic interaction between retigabine and phenobarbitone at steady-state in healthy subjects (Q42760045) (← links)
• Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI). (Q44154771) (← links)
• Synergy between retigabine and GABA in modulating the convulsant site of the GABAA receptor complex (Q44349595) (← links)
• Pharmacokinetic interaction between retigabine and lamotrigine in healthy subjects (Q44405609) (← links)
• Isobolographic characterization of interactions of retigabine with carbamazepine, lamotrigine, and valproate in the mouse maximal electroshock-induced seizure model. (Q46387953) (← links)
• The role of Gilbert's syndrome and frequent NAT2 slow acetylation polymorphisms in the pharmacokinetics of retigabine (Q46886423) (← links)
• Retigabine calms seizure-induced behavior following status epilepticus (Q47848016) (← links)
• Retigabine as adjunctive therapy in adults with partial-onset seizures: Integrated analysis of three pivotal controlled trials (Q83920798) (← links)